Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Jun 2001

Chang J, Hilsenbeck S G, Sng J H, Wong J, Ragu G C

Abstract excerpt

PURPOSE: Risk calculations for carrying BRCA1/BRCA2 mutations are based on family history and the age of onset of cancers. However, women may carry these deleterious mutations without a strong family history. Additional criteria for risk estimation would be of value. It has been recently established that BRCA1-associated breast cancers are associated with poor tumor differentiation (TD3) and estrogen receptor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genetic Testing

Share to Mutation

Share to Premenopause

Share to Receptors, Estrogen

Share to Risk Factors

Source

Identifiers

PMID: 11410514

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients.PMID 11410514Read ↗

Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer.Semantic proximity Read ↗

Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing.Semantic proximity Read ↗

Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancer.Semantic proximity Read ↗

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.Semantic proximity Read ↗

Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.Semantic proximity Read ↗

Prevalence of pre-malignant and malignant lesions in prophylactic mastectomy specimens of BRCA1 mutation carriers: comparison with a control group.Semantic proximity Read ↗

Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry.Semantic proximity Read ↗

Morphological predictors of BRCA1 germline mutations in young women with breast cancerSemantic proximity Read ↗

Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features.Semantic proximity Read ↗

Novel indications for BRCA1 screening using individual clinical and morphological features.Semantic proximity Read ↗

Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or less.Semantic proximity Read ↗

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.